AR089335A1 - Procedimiento de deteccion de una infeccion por el virus de la hepatitis c - Google Patents

Procedimiento de deteccion de una infeccion por el virus de la hepatitis c

Info

Publication number
AR089335A1
AR089335A1 ARP120104831A ARP120104831A AR089335A1 AR 089335 A1 AR089335 A1 AR 089335A1 AR P120104831 A ARP120104831 A AR P120104831A AR P120104831 A ARP120104831 A AR P120104831A AR 089335 A1 AR089335 A1 AR 089335A1
Authority
AR
Argentina
Prior art keywords
hepatitis
virus
infection
detection
hcv
Prior art date
Application number
ARP120104831A
Other languages
English (en)
Original Assignee
Bio Rad Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Innovations filed Critical Bio Rad Innovations
Publication of AR089335A1 publication Critical patent/AR089335A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente se refiere a un procedimiento de detección in vitro de una infección por un virus de la hepatitis C (VHC) en una muestra biológica, que comprende la detección simultánea de la proteína de cápside de VHC, y de un anticuerpo dirigido contra la citada proteína de cápside, que este procedimiento utiliza, para capturar los anticuerpos anticápside, que un péptido comprende un fragmento antigénico derivado de la cápside de VHC truncada. La presente se refiere también al péptido para capturar los anticuerpos anticápside y los kits que los comprenden.
ARP120104831A 2011-12-20 2012-12-19 Procedimiento de deteccion de una infeccion por el virus de la hepatitis c AR089335A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1161981A FR2984328B1 (fr) 2011-12-20 2011-12-20 Procede de detection d'une infection par le virus de l'hepatite c

Publications (1)

Publication Number Publication Date
AR089335A1 true AR089335A1 (es) 2014-08-13

Family

ID=47599082

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104831A AR089335A1 (es) 2011-12-20 2012-12-19 Procedimiento de deteccion de una infeccion por el virus de la hepatitis c

Country Status (12)

Country Link
US (2) US9719994B2 (es)
EP (1) EP2794638B1 (es)
JP (1) JP6312600B2 (es)
CN (1) CN104302660B (es)
AR (1) AR089335A1 (es)
AU (1) AU2012356512B2 (es)
BR (1) BR112014015201A2 (es)
CA (1) CA2859736C (es)
FR (1) FR2984328B1 (es)
MX (1) MX365962B (es)
TW (1) TW201337268A (es)
WO (1) WO2013093345A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
WO2021254476A1 (zh) * 2020-06-19 2021-12-23 南京金斯瑞生物科技有限公司 检测SARS-CoV-2病毒中和抗体的磁微粒化学发光试剂盒及其应用
WO2023207918A1 (en) * 2022-04-25 2023-11-02 Beijing Hanmoluojie Technology Co., Ltd. Aav capsid 3d molecular surface feature mapping

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693489A (en) 1984-03-30 1997-12-02 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5683864A (en) 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6027729A (en) 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
JP2733138B2 (ja) 1990-04-04 1998-03-30 カイロン コーポレイション 抗ｈｃｖ抗体の免疫アッセイに使用するｃ型肝炎ウイルス（ｈｃｖ）抗原の組合せ
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
UA40572C2 (uk) 1991-06-24 2001-08-15 Чірон Корпорейшн Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти)
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
JPH06511149A (ja) 1991-09-13 1994-12-15 カイロン　コーポレイション 免疫反応性ｃ型肝炎ウイルスのポリペプチド組成物
NZ299048A (en) 1992-03-06 1998-09-24 Innogenetics Sa Nv Modified peptides corresponding to immunologically useful epitopes in hiv, hcv and htlv and their use especially when biotinylated
FR2690921B1 (fr) 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
UA46707C2 (uk) 1993-05-10 2002-06-17 Чірон Корпорейшн Спосіб типування вірусу гепатиту с (варіанти), набір поліпептидів (варіанти), реагент, що включає комбінацію поліпептидів, які містять типоспецифічні епітопи гепатиту с (варіанти)
WO1994026306A1 (en) 1993-05-12 1994-11-24 Chiron Corporation Conserved motif of hepatitis c virus e2/ns1 region
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
JP3793571B2 (ja) 1994-07-29 2006-07-05 カイロン コーポレイション 新規ｃ型肝炎ｅ１およびｅ２短縮型ポリペプチドならびにこれらを得る方法
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
PT752102E (pt) 1995-01-23 2001-04-30 Pasteur Sanofi Diagnostics Conjugado imunoenzimatico seu processo de preparacao e as suas aplicacoes
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
JP3715027B2 (ja) 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
EP0870830A3 (en) 1997-02-10 2004-02-25 Advanced Life Science Institute, Inc. Chimera hepatitis C virus antigen
CA2607990C (en) 1997-08-04 2009-09-22 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
CA2491918C (en) 1997-08-04 2007-10-16 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
CN1207569C (zh) 1997-08-04 2005-06-22 株式会社先端生命科学研究所 用于测定含病毒样品的方法、病毒测定方法和诊断试剂盒
TR200003024T2 (tr) 1998-04-17 2000-12-21 Innogenetics N.V. İndirgeme ajanlarını kullanarak geliştirilen immünodiagnostik tahliller.
WO2000007023A1 (fr) 1998-07-30 2000-02-10 Advanced Life Science Institute, Inc. Procede pour la determination de l'hepatite a virus de type c
US6623921B2 (en) 1998-07-30 2003-09-23 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
CA2354152A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
WO2001009609A2 (en) 1999-07-28 2001-02-08 Chiron Corporation Hepatitis c viral antigen immunoassay detection systems
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
EP1350105B1 (en) 2000-06-15 2007-07-25 Novartis Vaccines and Diagnostics, Inc. Immunoassays for anti-hcv antibodies
SG118120A1 (en) 2001-03-28 2006-01-27 Ortho Clinical Diagnostics Inc A hepatitis C antigen - antibody combination assayfor the early detection of HCV infection
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
JP4353793B2 (ja) 2001-06-26 2009-10-28 アボット・ラボラトリーズ Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法
US7049060B2 (en) 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US20030108563A1 (en) * 2001-11-07 2003-06-12 Chander Bahl Reagents for the simultaneous detection of HCV core antigens and antibodies
US7332269B2 (en) 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
NZ538711A (en) 2002-09-09 2007-01-26 Chiron Corp Antigen/antibody/antigen sandwich assays for detecting hepatitis C virus infections
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
WO2010112733A1 (fr) * 2009-03-30 2010-10-07 bioMérieux Support solide de détection du vhc
US20100297607A1 (en) 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
CN102081018A (zh) 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法

Also Published As

Publication number Publication date
EP2794638A1 (fr) 2014-10-29
CN104302660A (zh) 2015-01-21
MX365962B (es) 2018-05-04
US9719994B2 (en) 2017-08-01
JP2015502552A (ja) 2015-01-22
US10345305B2 (en) 2019-07-09
FR2984328A1 (fr) 2013-06-21
WO2013093345A1 (fr) 2013-06-27
FR2984328B1 (fr) 2016-12-30
CA2859736A1 (fr) 2013-06-27
CA2859736C (fr) 2021-03-30
EP2794638B1 (fr) 2020-05-27
JP6312600B2 (ja) 2018-04-18
AU2012356512A1 (en) 2014-07-24
MX2014007437A (es) 2015-03-03
TW201337268A (zh) 2013-09-16
US20140335508A1 (en) 2014-11-13
US20170328905A1 (en) 2017-11-16
AU2012356512B2 (en) 2017-07-20
BR112014015201A2 (pt) 2019-09-24
CN104302660B (zh) 2018-04-20

Similar Documents

Publication Publication Date Title
MX2019001767A (es) Anticuerpos monoclonales que se unen al dominio de union a lipidos de la proteina de la capside del virus de la hepatitis c (vhc).
EA201391170A1 (ru) Терапевтическое средство на основе дрожжей для лечения хронического гепатита b
CL2013003248A1 (es) Composición inmunogenica que comprende una glucoproteina g de los virus hendra y nipah y un complejo inmunoestimulante; método para producir una respuesta de anticuerpo neutralizante contra un virus hendra y/o nipah en un sujeto.
CR20130609A (es) Eliminación de células diana por parte de células t citotóxicas específicas de virus utilizando complejos que comprenden mhc de clase 1
EA201071086A1 (ru) Усовершенствованный способ получения вакцинных антигенов вируса гриппа
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
ECSP11010823A (es) Anticuerpos neutralizantes del virus anti-influenza a y usos de los mismos
MX2009006469A (es) Metodo de duplicacion del virus de la influenza en cultivo.
ES2562774T3 (es) Vacunas para la gripe basadas en el virus del mosaico de la papaya
EA201071087A1 (ru) Моноклональные антитела, способные взаимодействовать с множеством подтипов вируса гриппа а
WO2014134561A3 (en) Quantification of vaccine compositions
ES2421543T3 (es) Método para la preparación de virus y proteínas del PRRS, y kits de pruebas de diagnóstico para su detección
AR071220A1 (es) Astrovirus aviario depositado bajo el nuero cncm i-3895
EA201390806A1 (ru) Конструкция пептидного каркаса
CY1121856T1 (el) Αντισωματα εξουδετερωσης jcv
WO2013001285A3 (en) Fmdv vp1 peptides
AR089335A1 (es) Procedimiento de deteccion de una infeccion por el virus de la hepatitis c
PE20180576A1 (es) ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh
WO2015196192A3 (en) Methods and compositions relating to dengue virus
EA201291437A1 (ru) Концентрация вакцинных антигенов без лиофилизации
WO2014128568A3 (en) Compositions and methods for treatment of hepatitis c
TW200734463A (en) Marked bovine viral diarrhea virus vaccines
MY181007A (en) Scale drop disease (sdd) causative virus and derivatives thereof
WO2007108568A8 (en) Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
AR094810A1 (es) Parvovirus porcino 5b, métodos de uso y vacuna

Legal Events

Date Code Title Description
FB Suspension of granting procedure